

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin filament-based movement (GO:0030048) | 8.16845302 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 8.08211572 |
| 3 | myofibril assembly (GO:0030239) | 7.67236000 |
| 4 | striated muscle contraction (GO:0006941) | 7.65815134 |
| 5 | sarcomere organization (GO:0045214) | 7.15366970 |
| 6 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 7.08792218 |
| 7 | response to muscle activity (GO:0014850) | 7.07769362 |
| 8 | creatine metabolic process (GO:0006600) | 7.00962702 |
| 9 | skeletal muscle adaptation (GO:0043501) | 6.85560350 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.81685985 |
| 11 | skeletal muscle fiber development (GO:0048741) | 6.80790904 |
| 12 | response to inactivity (GO:0014854) | 6.52887996 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.28453902 |
| 14 | myotube cell development (GO:0014904) | 6.19151511 |
| 15 | plasma membrane repair (GO:0001778) | 5.95478545 |
| 16 | muscle contraction (GO:0006936) | 5.86239291 |
| 17 | cardiac myofibril assembly (GO:0055003) | 5.71769102 |
| 18 | actomyosin structure organization (GO:0031032) | 5.51282833 |
| 19 | glycogen catabolic process (GO:0005980) | 5.43491974 |
| 20 | cardiac muscle contraction (GO:0060048) | 5.30393110 |
| 21 | muscle system process (GO:0003012) | 5.26304134 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.16352465 |
| 23 | glucan catabolic process (GO:0009251) | 5.11402644 |
| 24 | glycogen biosynthetic process (GO:0005978) | 5.06776517 |
| 25 | glucan biosynthetic process (GO:0009250) | 5.06776517 |
| 26 | muscle fiber development (GO:0048747) | 5.03741520 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.02975657 |
| 28 | muscle cell fate commitment (GO:0042693) | 5.02944248 |
| 29 | skeletal muscle tissue development (GO:0007519) | 5.00845303 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.95579691 |
| 31 | striated muscle adaptation (GO:0014888) | 4.89502116 |
| 32 | striated muscle hypertrophy (GO:0014897) | 4.82938624 |
| 33 | cellular polysaccharide catabolic process (GO:0044247) | 4.79510719 |
| 34 | skeletal muscle tissue regeneration (GO:0043403) | 4.73946341 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 4.69117251 |
| 36 | NADH metabolic process (GO:0006734) | 4.68409585 |
| 37 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.51720930 |
| 38 | cardiac muscle hypertrophy (GO:0003300) | 4.51440723 |
| 39 | muscle cell cellular homeostasis (GO:0046716) | 4.45725754 |
| 40 | muscle hypertrophy (GO:0014896) | 4.32641500 |
| 41 | polysaccharide catabolic process (GO:0000272) | 4.32128699 |
| 42 | positive regulation of myotube differentiation (GO:0010831) | 4.24957552 |
| 43 | striated muscle atrophy (GO:0014891) | 4.08033714 |
| 44 | muscle structure development (GO:0061061) | 4.06496290 |
| 45 | muscle organ development (GO:0007517) | 4.06095706 |
| 46 | glycogen metabolic process (GO:0005977) | 4.02656621 |
| 47 | fructose metabolic process (GO:0006000) | 3.97637461 |
| 48 | cellular glucan metabolic process (GO:0006073) | 3.94842256 |
| 49 | glucan metabolic process (GO:0044042) | 3.94842256 |
| 50 | muscle adaptation (GO:0043500) | 3.94675143 |
| 51 | otic vesicle formation (GO:0030916) | 3.92022498 |
| 52 | striated muscle cell development (GO:0055002) | 3.91794549 |
| 53 | muscle tissue morphogenesis (GO:0060415) | 3.89176902 |
| 54 | regulation of striated muscle contraction (GO:0006942) | 3.86789942 |
| 55 | myoblast fusion (GO:0007520) | 3.85085892 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 3.84161321 |
| 57 | muscle organ morphogenesis (GO:0048644) | 3.79991785 |
| 58 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.78565554 |
| 59 | response to activity (GO:0014823) | 3.75048999 |
| 60 | gluconeogenesis (GO:0006094) | 3.73771753 |
| 61 | muscle atrophy (GO:0014889) | 3.66682881 |
| 62 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.66617296 |
| 63 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.66457833 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.63954576 |
| 65 | regulation of myoblast differentiation (GO:0045661) | 3.63661175 |
| 66 | adult heart development (GO:0007512) | 3.62729954 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.62459975 |
| 68 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.62459975 |
| 69 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.61970878 |
| 70 | myotube differentiation (GO:0014902) | 3.55316345 |
| 71 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.54860532 |
| 72 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.54860532 |
| 73 | cardiac muscle cell development (GO:0055013) | 3.53984687 |
| 74 | carnitine shuttle (GO:0006853) | 3.52236545 |
| 75 | tricarboxylic acid cycle (GO:0006099) | 3.50109073 |
| 76 | negative regulation of muscle contraction (GO:0045932) | 3.48757921 |
| 77 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.47861497 |
| 78 | positive regulation of myoblast differentiation (GO:0045663) | 3.41938466 |
| 79 | muscle cell development (GO:0055001) | 3.41371481 |
| 80 | striated muscle tissue development (GO:0014706) | 3.39457081 |
| 81 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.36951355 |
| 82 | hexose biosynthetic process (GO:0019319) | 3.34355605 |
| 83 | IMP metabolic process (GO:0046040) | 3.34342620 |
| 84 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.31134554 |
| 85 | cardiac cell development (GO:0055006) | 3.28093023 |
| 86 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.26899419 |
| 87 | cardiac muscle adaptation (GO:0014887) | 3.22359679 |
| 88 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.22359679 |
| 89 | muscle hypertrophy in response to stress (GO:0003299) | 3.22359679 |
| 90 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.16671007 |
| 91 | regulation of myotube differentiation (GO:0010830) | 3.14409954 |
| 92 | regulation of muscle system process (GO:0090257) | 3.13911790 |
| 93 | relaxation of muscle (GO:0090075) | 3.13531012 |
| 94 | regulation of the force of heart contraction (GO:0002026) | 3.11890410 |
| 95 | actin-myosin filament sliding (GO:0033275) | 13.3084503 |
| 96 | muscle filament sliding (GO:0030049) | 13.3084503 |
| 97 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.3775540 |
| 98 | skeletal muscle contraction (GO:0003009) | 10.9827108 |
| 99 | actin-mediated cell contraction (GO:0070252) | 10.9510448 |
| 100 | regulation of skeletal muscle contraction (GO:0014819) | 10.2306527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.73234220 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.79467704 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.06191847 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.50014753 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.28755899 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.03156099 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.91787650 |
| 8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.91787650 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.66425750 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.56294977 |
| 11 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.44177071 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.41369034 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33903676 |
| 14 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.22420124 |
| 15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.18796364 |
| 16 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.16661850 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.06147171 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85706534 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77359769 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66137042 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.65859819 |
| 22 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.62027349 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58916675 |
| 24 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.51533460 |
| 25 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.49932351 |
| 26 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.47508838 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47218116 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43975578 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40443015 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35842918 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33403387 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33173667 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28296532 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24530777 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24041400 |
| 36 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20455629 |
| 37 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.15756185 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11719128 |
| 39 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10246107 |
| 40 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10108104 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09889965 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08108656 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06529857 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05467032 |
| 45 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05402451 |
| 46 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03508951 |
| 47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02511432 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02126354 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01525229 |
| 50 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01093908 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00648672 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99095969 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97854437 |
| 54 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.97739156 |
| 55 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97286252 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97243548 |
| 57 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96883149 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96268653 |
| 59 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95912363 |
| 60 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95354585 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95030878 |
| 62 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94474617 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94451482 |
| 64 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94295975 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94257264 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91087297 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90784084 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90500746 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89123826 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89123826 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89057845 |
| 72 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.89026443 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87685393 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.87206222 |
| 75 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85746635 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85281410 |
| 77 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84913428 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84446412 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84062140 |
| 80 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83968351 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83930699 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83178660 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81703850 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.81020512 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78927066 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78113785 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77174100 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76802189 |
| 89 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76201118 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74984187 |
| 91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.74153127 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.74027897 |
| 93 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.73964628 |
| 94 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.73147311 |
| 95 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72775439 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72490385 |
| 97 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.71933106 |
| 98 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.71897574 |
| 99 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.71897574 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.71528484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.93720428 |
| 2 | MP0003646_muscle_fatigue | 6.78133040 |
| 3 | MP0000751_myopathy | 6.08898706 |
| 4 | MP0000749_muscle_degeneration | 5.98108849 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.26114659 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.81863939 |
| 7 | MP0000747_muscle_weakness | 3.64045394 |
| 8 | MP0004087_abnormal_muscle_fiber | 3.58734089 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.56709175 |
| 10 | MP0005451_abnormal_body_composition | 3.33818598 |
| 11 | MP0005369_muscle_phenotype | 3.26155548 |
| 12 | MP0002332_abnormal_exercise_endurance | 3.10643971 |
| 13 | MP0002269_muscular_atrophy | 3.06085478 |
| 14 | MP0004084_abnormal_cardiac_muscle | 3.03899074 |
| 15 | MP0000750_abnormal_muscle_regeneration | 3.00740515 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.87237133 |
| 17 | MP0004130_abnormal_muscle_cell | 2.85752861 |
| 18 | MP0004233_abnormal_muscle_weight | 2.83806807 |
| 19 | MP0005330_cardiomyopathy | 2.63908984 |
| 20 | MP0000733_abnormal_muscle_development | 2.33322315 |
| 21 | MP0002108_abnormal_muscle_morphology | 2.12719863 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.08970846 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.98979797 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.87083737 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.75466331 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.73411098 |
| 27 | MP0004484_altered_response_of | 1.71654447 |
| 28 | MP0004270_analgesia | 1.63148044 |
| 29 | MP0010630_abnormal_cardiac_muscle | 1.58213164 |
| 30 | MP0001661_extended_life_span | 1.46877420 |
| 31 | MP0004510_myositis | 1.43273282 |
| 32 | MP0005266_abnormal_metabolism | 1.42908291 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.40929119 |
| 34 | MP0006138_congestive_heart_failure | 1.28543373 |
| 35 | MP0005385_cardiovascular_system_phenoty | 1.28103708 |
| 36 | MP0001544_abnormal_cardiovascular_syste | 1.28103708 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.19718890 |
| 38 | MP0002971_abnormal_brown_adipose | 1.14145016 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11191688 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 0.98436569 |
| 41 | MP0002822_catalepsy | 0.92526387 |
| 42 | MP0005375_adipose_tissue_phenotype | 0.90186045 |
| 43 | MP0000003_abnormal_adipose_tissue | 0.89864946 |
| 44 | MP0003137_abnormal_impulse_conducting | 0.86313562 |
| 45 | MP0005666_abnormal_adipose_tissue | 0.85656846 |
| 46 | MP0008775_abnormal_heart_ventricle | 0.79987777 |
| 47 | MP0010030_abnormal_orbit_morphology | 0.76258308 |
| 48 | MP0003879_abnormal_hair_cell | 0.75711135 |
| 49 | MP0005670_abnormal_white_adipose | 0.71315589 |
| 50 | MP0003045_fibrosis | 0.71051641 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 0.70231413 |
| 52 | MP0004085_abnormal_heartbeat | 0.69655485 |
| 53 | MP0004147_increased_porphyrin_level | 0.67456649 |
| 54 | MP0003828_pulmonary_edema | 0.66049966 |
| 55 | MP0001299_abnormal_eye_distance/ | 0.63578868 |
| 56 | MP0004043_abnormal_pH_regulation | 0.61529994 |
| 57 | MP0000266_abnormal_heart_morphology | 0.61505695 |
| 58 | MP0000372_irregular_coat_pigmentation | 0.59156206 |
| 59 | MP0004134_abnormal_chest_morphology | 0.56597315 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 0.56187532 |
| 61 | MP0003878_abnormal_ear_physiology | 0.56187532 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 0.53705490 |
| 63 | MP0009250_abnormal_appendicular_skeleto | 0.49233516 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.47166350 |
| 65 | MP0009672_abnormal_birth_weight | 0.46504858 |
| 66 | MP0000762_abnormal_tongue_morphology | 0.44741820 |
| 67 | MP0001346_abnormal_lacrimal_gland | 0.43554572 |
| 68 | MP0002128_abnormal_blood_circulation | 0.41024350 |
| 69 | MP0005083_abnormal_biliary_tract | 0.40863862 |
| 70 | MP0004142_abnormal_muscle_tone | 0.39983730 |
| 71 | MP0008569_lethality_at_weaning | 0.39307030 |
| 72 | MP0002114_abnormal_axial_skeleton | 0.38605055 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37901268 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 0.35877923 |
| 75 | MP0005248_abnormal_Harderian_gland | 0.35265372 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.33908319 |
| 77 | MP0005535_abnormal_body_temperature | 0.33642025 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.32799571 |
| 79 | MP0003948_abnormal_gas_homeostasis | 0.32401773 |
| 80 | MP0005166_decreased_susceptibility_to | 0.32397914 |
| 81 | MP0005452_abnormal_adipose_tissue | 0.32013442 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.30562736 |
| 83 | MP0002734_abnormal_mechanical_nocicepti | 0.30360203 |
| 84 | MP0002102_abnormal_ear_morphology | 0.29791130 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.29059949 |
| 86 | MP0005332_abnormal_amino_acid | 0.28306464 |
| 87 | MP0005334_abnormal_fat_pad | 0.24776319 |
| 88 | MP0001943_abnormal_respiration | 0.23970744 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.23116369 |
| 90 | MP0005165_increased_susceptibility_to | 0.22935494 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.21806953 |
| 92 | MP0002249_abnormal_larynx_morphology | 0.21187900 |
| 93 | MP0003941_abnormal_skin_development | 0.21153868 |
| 94 | MP0005187_abnormal_penis_morphology | 0.18984422 |
| 95 | MP0000579_abnormal_nail_morphology | 0.18675517 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 0.18670144 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.18429003 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.18365340 |
| 99 | MP0004197_abnormal_fetal_growth/weight/ | 0.17778140 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.17601812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.36185033 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.02190310 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.34711380 |
| 4 | Distal arthrogryposis (HP:0005684) | 7.14830893 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.06132149 |
| 6 | Myopathic facies (HP:0002058) | 5.83868877 |
| 7 | Round ear (HP:0100830) | 5.56327178 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.50530234 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 5.26337938 |
| 10 | EMG: myopathic abnormalities (HP:0003458) | 5.22228787 |
| 11 | Muscle fiber splitting (HP:0003555) | 4.89966588 |
| 12 | Rhabdomyolysis (HP:0003201) | 4.68468208 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 4.64628097 |
| 14 | Myoglobinuria (HP:0002913) | 4.59699984 |
| 15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.56741570 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 4.55004838 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.53441156 |
| 18 | Neck muscle weakness (HP:0000467) | 4.47275203 |
| 19 | Absent phalangeal crease (HP:0006109) | 4.26323036 |
| 20 | Rimmed vacuoles (HP:0003805) | 4.24002596 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.18497760 |
| 22 | Deformed tarsal bones (HP:0008119) | 4.13669938 |
| 23 | Difficulty running (HP:0009046) | 3.95631285 |
| 24 | Subaortic stenosis (HP:0001682) | 3.92232696 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.92232696 |
| 26 | Increased connective tissue (HP:0009025) | 3.67045552 |
| 27 | Muscle stiffness (HP:0003552) | 3.61620434 |
| 28 | Malignant hyperthermia (HP:0002047) | 3.55229558 |
| 29 | Abnormal finger flexion creases (HP:0006143) | 3.54667893 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.48176442 |
| 31 | Frequent falls (HP:0002359) | 3.40710510 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 3.32032653 |
| 33 | Myotonia (HP:0002486) | 3.23276924 |
| 34 | Fetal akinesia sequence (HP:0001989) | 3.19708002 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.16941532 |
| 36 | Areflexia of lower limbs (HP:0002522) | 3.12182665 |
| 37 | Sudden death (HP:0001699) | 3.08548864 |
| 38 | EMG: neuropathic changes (HP:0003445) | 2.91888635 |
| 39 | Generalized muscle weakness (HP:0003324) | 2.90588428 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.82523916 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 2.72611591 |
| 42 | Bundle branch block (HP:0011710) | 2.70955051 |
| 43 | Bulbar palsy (HP:0001283) | 2.64814219 |
| 44 | Slender build (HP:0001533) | 2.60060606 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.57586396 |
| 46 | Hyperkalemia (HP:0002153) | 2.50155001 |
| 47 | Weak cry (HP:0001612) | 2.49900162 |
| 48 | Gowers sign (HP:0003391) | 2.42935311 |
| 49 | Fatigable weakness (HP:0003473) | 2.37809986 |
| 50 | Abnormality of the neuromuscular junction (HP:0003398) | 2.37809986 |
| 51 | Hip contracture (HP:0003273) | 2.37669797 |
| 52 | Scapular winging (HP:0003691) | 2.37018028 |
| 53 | Limb-girdle muscle atrophy (HP:0003797) | 2.29952401 |
| 54 | Spinal rigidity (HP:0003306) | 2.28940387 |
| 55 | Dilated cardiomyopathy (HP:0001644) | 2.28761682 |
| 56 | Popliteal pterygium (HP:0009756) | 2.18319859 |
| 57 | Ventricular tachycardia (HP:0004756) | 2.17334390 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.15938365 |
| 59 | Difficulty climbing stairs (HP:0003551) | 2.09938326 |
| 60 | Muscular dystrophy (HP:0003560) | 2.07082632 |
| 61 | Waddling gait (HP:0002515) | 2.05678721 |
| 62 | Lipoatrophy (HP:0100578) | 2.02686705 |
| 63 | Proximal amyotrophy (HP:0007126) | 2.02523873 |
| 64 | Metatarsus adductus (HP:0001840) | 2.01805397 |
| 65 | Muscle fiber inclusion bodies (HP:0100299) | 11.3037813 |
| 66 | Nemaline bodies (HP:0003798) | 11.2837024 |
| 67 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.9956374 |
| 68 | Lower limb amyotrophy (HP:0007210) | 1.95949077 |
| 69 | Long clavicles (HP:0000890) | 1.94996930 |
| 70 | Nonprogressive disorder (HP:0003680) | 1.93019259 |
| 71 | Abnormality of the foot musculature (HP:0001436) | 1.92704594 |
| 72 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.90535311 |
| 73 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84516891 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 1.78734066 |
| 75 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75887723 |
| 76 | Ulnar deviation of finger (HP:0009465) | 1.73983009 |
| 77 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.73815412 |
| 78 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.73815412 |
| 79 | Facial diplegia (HP:0001349) | 1.72523807 |
| 80 | Heart block (HP:0012722) | 1.71394832 |
| 81 | Shoulder girdle muscle weakness (HP:0003547) | 1.67011427 |
| 82 | Paralysis (HP:0003470) | 1.66335151 |
| 83 | Pelvic girdle muscle weakness (HP:0003749) | 1.66148219 |
| 84 | Exercise intolerance (HP:0003546) | 1.63001011 |
| 85 | Limb-girdle muscle weakness (HP:0003325) | 1.61765388 |
| 86 | Muscle fiber atrophy (HP:0100295) | 1.61309462 |
| 87 | Abnormal atrioventricular conduction (HP:0005150) | 1.61113575 |
| 88 | Limited hip movement (HP:0008800) | 1.60393840 |
| 89 | Breech presentation (HP:0001623) | 1.59700819 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 1.57536202 |
| 91 | Amniotic constriction ring (HP:0009775) | 1.56252941 |
| 92 | Abnormality of placental membranes (HP:0011409) | 1.56252941 |
| 93 | Aplasia of the musculature (HP:0100854) | 1.47108738 |
| 94 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.44316603 |
| 95 | Oligomenorrhea (HP:0000876) | 1.42518058 |
| 96 | Adducted thumb (HP:0001181) | 1.39762025 |
| 97 | Ventricular arrhythmia (HP:0004308) | 1.37143211 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.36091179 |
| 99 | Easy fatigability (HP:0003388) | 1.32787812 |
| 100 | Steppage gait (HP:0003376) | 1.31296991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG1 | 5.84490414 |
| 2 | PHKG2 | 5.84490414 |
| 3 | TTN | 5.82491248 |
| 4 | PIK3CG | 3.09325491 |
| 5 | OBSCN | 11.4074839 |
| 6 | PINK1 | 1.92428419 |
| 7 | MAPK12 | 1.89949095 |
| 8 | MUSK | 1.70984376 |
| 9 | MAP2K3 | 1.67880231 |
| 10 | MAP3K7 | 1.65449193 |
| 11 | MOS | 1.33262256 |
| 12 | MAPKAPK3 | 1.31151812 |
| 13 | TRPM7 | 1.29597722 |
| 14 | EEF2K | 1.17261963 |
| 15 | NME1 | 1.15386250 |
| 16 | CCNB1 | 1.11700714 |
| 17 | MAP2K4 | 1.08600064 |
| 18 | MARK1 | 0.95189380 |
| 19 | NEK1 | 0.91067596 |
| 20 | LIMK1 | 0.89564181 |
| 21 | CAMK2G | 0.86306741 |
| 22 | DMPK | 0.84630921 |
| 23 | PRKAA2 | 0.80750183 |
| 24 | MAP3K13 | 0.79228254 |
| 25 | MAP2K6 | 0.75078395 |
| 26 | ERBB3 | 0.73114916 |
| 27 | AKT2 | 0.71812987 |
| 28 | MAPK7 | 0.69044861 |
| 29 | TRIB3 | 0.67178248 |
| 30 | PDK2 | 0.66945383 |
| 31 | DYRK1B | 0.65303532 |
| 32 | PRKAA1 | 0.63945860 |
| 33 | RIPK1 | 0.61731865 |
| 34 | NEK9 | 0.55074372 |
| 35 | CAMK2B | 0.54058516 |
| 36 | CAMK4 | 0.51866828 |
| 37 | KSR2 | 0.51263990 |
| 38 | MAP2K1 | 0.50553113 |
| 39 | PRKG1 | 0.50511012 |
| 40 | MAPK11 | 0.49967331 |
| 41 | MAPK4 | 0.49505762 |
| 42 | PKN1 | 0.47398878 |
| 43 | BCKDK | 0.45926982 |
| 44 | PIK3CA | 0.44466793 |
| 45 | SGK3 | 0.43945598 |
| 46 | CAMK2D | 0.43386768 |
| 47 | TIE1 | 0.41914853 |
| 48 | LATS2 | 0.41436686 |
| 49 | ICK | 0.39435276 |
| 50 | CAMK2A | 0.38177332 |
| 51 | ROCK1 | 0.36830036 |
| 52 | CAMK1 | 0.35231291 |
| 53 | SGK2 | 0.33934195 |
| 54 | MAP3K1 | 0.31951836 |
| 55 | PRKACA | 0.30341664 |
| 56 | TBK1 | 0.29990278 |
| 57 | ARAF | 0.29125000 |
| 58 | SGK1 | 0.26685989 |
| 59 | RPS6KA3 | 0.25728465 |
| 60 | EPHB1 | 0.25704217 |
| 61 | RPS6KB1 | 0.25699256 |
| 62 | MAP3K10 | 0.24942425 |
| 63 | MAPK13 | 0.22881538 |
| 64 | TAOK2 | 0.22353838 |
| 65 | MARK2 | 0.20950783 |
| 66 | LATS1 | 0.20853101 |
| 67 | PRKACB | 0.20708886 |
| 68 | PDPK1 | 0.20513549 |
| 69 | MAPK10 | 0.20186569 |
| 70 | RPS6KB2 | 0.19701293 |
| 71 | RPS6KA1 | 0.18470440 |
| 72 | TGFBR2 | 0.18456392 |
| 73 | SIK1 | 0.18156012 |
| 74 | NLK | 0.16611931 |
| 75 | PDK1 | 0.16525297 |
| 76 | CDK19 | 0.15927197 |
| 77 | SGK494 | 0.15371781 |
| 78 | SGK223 | 0.15371781 |
| 79 | RPS6KL1 | 0.14679922 |
| 80 | RPS6KC1 | 0.14679922 |
| 81 | STK11 | 0.13703053 |
| 82 | DAPK2 | 0.13328972 |
| 83 | MTOR | 0.13054383 |
| 84 | PRPF4B | 0.12577510 |
| 85 | EPHA3 | 0.12399377 |
| 86 | PRKACG | 0.10834021 |
| 87 | MAP3K9 | 0.10641412 |
| 88 | RPS6KA6 | 0.10630171 |
| 89 | RAF1 | 0.10412639 |
| 90 | MAP3K6 | 0.10352295 |
| 91 | PRKD1 | 0.08930197 |
| 92 | MARK3 | 0.08561055 |
| 93 | MAP3K11 | 0.07309682 |
| 94 | MAP3K3 | 0.07107305 |
| 95 | BRAF | 0.05811894 |
| 96 | FGFR3 | 0.05621622 |
| 97 | MAPKAPK5 | 0.04787669 |
| 98 | KSR1 | 0.03978097 |
| 99 | RPS6KA2 | 0.03578752 |
| 100 | ZAP70 | 0.03560132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.60242843 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.16384145 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.07012473 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.69278761 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.60619516 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.38939751 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.28837388 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.97615388 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.36559347 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.22218607 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.19769612 |
| 12 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.12815532 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.09862065 |
| 14 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.03904555 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.86338983 |
| 16 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79907410 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.79481997 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77335891 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.75814566 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.67980980 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.61215397 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59150765 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53062413 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49835323 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48910351 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46215580 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.45141175 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33388773 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.32833509 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29015182 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28005873 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.23314723 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13802904 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11211847 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09241905 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06629695 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.02994142 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02693759 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.02136019 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.00864847 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99343724 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 0.93081163 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83574734 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 0.82697636 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81930180 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81515304 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80475841 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79280759 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75295701 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74105496 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61812646 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61348649 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60411271 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 0.57278774 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57029091 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55141824 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.52880751 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50970507 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50407460 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49331336 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46905189 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45074126 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44044572 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43518798 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42410250 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.41456510 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.41354198 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.41188489 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38504558 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37360730 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35428555 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34709096 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33331199 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32867348 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.31572792 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30786747 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30642865 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29944095 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.29599428 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26468687 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26332714 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26320999 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25772661 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25401490 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24245890 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.23820565 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22644926 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.21827496 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21372355 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21011072 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.20589849 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.20427030 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18886566 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18458834 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18117752 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17165681 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14725369 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13503336 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12270087 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.11562000 |

